Renalytix Receives Written Notification From Nasdaq On August 23, 2024 That Following The Presentation Of Its Operating And Financing Plan, The Co Has Been Granted An Extension Until October 25, 2024 To Regain Compliance With The Minimum Bid Price Requirement And Other Applicable Nasdaq Listing Requirements
- SEC Filing